Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum respiratory challenge.
Res Sq [Preprint]. 2023 Dec 11:rs.3.rs-3688658. doi: 10.21203/rs.3.rs-3688658/v1.
Res Sq. 2023.
PMID: 38168233
Free PMC article.
Preprint.
Evaluation of Four Adjuvant Combinations, IVAX-1, IVAX-2, CpG-1826+Montanide ISA 720 VG and CpG-1018+Montanide ISA 720 VG, for Safety and for Their Ability to Elicit Protective Immune Responses in Mice against a Respiratory Challenge with Chlamydia muridarum.
Pal S, Slepenkin A, Felgner J, Huw Davies D, Felgner P, de la Maza LM.
Pal S, et al. Among authors: slepenkin a.
Pathogens. 2023 Jun 22;12(7):863. doi: 10.3390/pathogens12070863.
Pathogens. 2023.
PMID: 37513710
Free PMC article.
Item in Clipboard
The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane Protein to Elicit Protective Immune Responses against a Chlamydia muridarum Respiratory Challenge.
Slepenkin A, Pal S, Hoang-Phou S, Abisoye-Ogunniyan A, Rasley A, D'haeseleer P, Coleman MA, de la Maza LM.
Slepenkin A, et al.
Vaccines (Basel). 2023 Feb 21;11(3):504. doi: 10.3390/vaccines11030504.
Vaccines (Basel). 2023.
PMID: 36992088
Free PMC article.
Item in Clipboard
Cite
Cite